|
Market Closed -
NYSE
00:00:02 31/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 229.94 USD | -9.05% |
|
-9.06% | -4.54% |
| 10-30 | RBC Raises Price Target on ResMed to $288 From $262, Keeps Outperform Rating | MT |
| 10-30 | Citigroup Adjusts Price Target on ResMed to $270 From $240 | MT |
Chart: Technical Analysis
NYSEUSD
| Markets | Quality | ||
|---|---|---|---|
NYSE
| RMD | Delayed | |
CBOE
| RMD | Real-time | |
|
Tradegate
| RME | Real-time | |
|
Börse Stuttgart
| RME | Delayed | |
|
Xetra
| RME | Delayed | |
|
Boerse Muenchen
| RME | Real-time | |
|
Wiener Boerse
| RMD | End-of-day quote | |
|
Berne S.E.
| RME | End-of-day quote | |
|
Mexican S.E.
| RMD * | End-of-day quote | |
|
London S.E.
| 0KW4 | Delayed | |
|
Deutsche Boerse AG
| RME | Delayed | |
|
Borsa Italiana
| 1RMD | End-of-day quote | |
Australian S.E.
| RMD | Delayed | |
|
Börse Stuttgart
| RMEA | Delayed | |
|
Deutsche Boerse AG
| RMEA | Delayed | |
|
OTC Markets
| RSMDF | Delayed | |
|
Tradegate
| RMEA | Real-time | |
|
Boerse Muenchen
| RMEA | Real-time | |
Sao Paulo
| R1MD34 | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Neutral |
| Resistance | 253.2 | 253.2 | 271.63 |
| Spread/Res. | -9.19% | -9.19% | -15.35% |
| Spread/Supp. | +5.05% | +5.05% | +21.90% |
| Support | 218.89 | 218.89 | 188.63 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- RMD Stock
- Charts ResMed, Inc.
Select your edition
All financial news and data tailored to specific country editions
